Literature DB >> 23411054

Pleural fluid biomarkers: beyond the Light criteria.

José M Porcel1.   

Abstract

Although distinguishing transudates from exudates through the Light criteria is still considered a pragmatic first step in the diagnostic work-up of pleural effusions, the measurement of various pleural fluid biomarkers may aid in the identification of common and specific entities, such as heart failure (natriuretic peptides), tuberculosis (adenosine deaminase), malignancy (mesothelin, fibulin-3, immunocytochemical stains), or bacterial pleural infections (C-reactive protein). The use of these biomarkers is currently encouraged as a routine diagnostic procedure.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411054     DOI: 10.1016/j.ccm.2012.11.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  19 in total

1.  Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion.

Authors:  Y Murata; K Aoe; Y Mimura-Kimura; T Murakami; K Oishi; T Matsumoto; H Ueoka; K Matsunaga; M Yano; Y Mimura
Journal:  Clin Exp Immunol       Date:  2017-07-17       Impact factor: 4.330

Review 2.  Tuberculous Pleural Effusion.

Authors:  Leah A Cohen; Richard W Light
Journal:  Turk Thorac J       Date:  2015-01-01

3.  Role of blind closed pleural biopsy in the managment of pleural exudates.

Authors:  Marco F Pereyra; Esther San-José; Lucía Ferreiro; Antonio Golpe; José Antúnez; Francisco-Javier González-Barcala; Ihab Abdulkader; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Luis Valdés
Journal:  Can Respir J       Date:  2013-08-15       Impact factor: 2.409

Review 4.  Current best practice in the evaluation and management of malignant pleural effusions.

Authors:  Steven Walker; Anna C Bibby; Nick A Maskell
Journal:  Ther Adv Respir Dis       Date:  2016-10-24       Impact factor: 4.031

5.  High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.

Authors:  Yin Tang; Zhuo Wang; Ziming Li; Jungwoo Kim; Yuliang Deng; Yan Li; James R Heath; Wei Wei; Shun Lu; Qihui Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

6.  Combined evaluation of adenosine deaminase level and histopathological findings from pleural biopsy with Cope's needle for the diagnosis of tuberculous pleurisy.

Authors:  Rodolfo Fred Behrsin; Cyro Teixeira da Silva Junior; Gilberto Perez Cardoso; Jorge Luiz Barillo; Joeber Bernardo Soares de Souza; Elizabeth Giestal de Araújo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.

Authors:  Silvia Bielsa; Horacio Valencia; Agustín Ruiz-González; Aureli Esquerda; José M Porcel
Journal:  Lung       Date:  2014-06-10       Impact factor: 2.584

8.  Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.

Authors:  Dajiang Li; Yongchun Shen; Jiangyue Qin; Chun Wan; Ni Zeng; Lei Chen; Yue Dong
Journal:  Ann Transl Med       Date:  2019-01

Review 9.  Malignant pleural effusion: medical approaches for diagnosis and management.

Authors:  Hae-Seong Nam
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-05-29

10.  Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions.

Authors:  Qiaoying Ji; Bifei Huang; Maofeng Wang; Zhaoxiang Ren; Sha Zhang; Yongjun Zhang; Lijian Sheng; Yayao Yu; Jinwen Jiang; Debao Chen; Jun Ying; Jiong Yu; Liuyi Qiu; Rugen Wan; Weimin Li
Journal:  Exp Ther Med       Date:  2014-01-27       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.